SECRETED AND CELLULAR PROTEOCHONDROITIN SULFATES OF A HUMAN B-LYMPHOBLASTOID CELL-LINE CONTAIN DIFFERENT PROTEIN CORES

被引:0
|
作者
BUTZ, H
STUHLSATZ, HW
MAIER, G
SCHWARTZALBIEZ, R
机构
[1] GERMAN CANC RES CTR,INST IMMUNOL & GENET,NEUENHEIMER FELD 280,W-6900 HEIDELBERG,GERMANY
[2] GERMAN CANC RES CTR,INST CELL & TUMORBIOL,W-6900 HEIDELBERG,GERMANY
[3] RHEIN WESTFAL TH AACHEN,FAC MED,DEPT CLIN CHEM & PATHOBIOCHEM,W-5100 AACHEN,GERMANY
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteoglycans of the human B lymphoblastoid cell line LICR-LON-HMy2 were metabolically labeled with [S-35]sulfate. High-density fractions of S-35-labeled material separated by CsCl gradient ultracentrifugation were further purified by anion exchange chromatography and gel filtration. Two proteoglycans, isolated from cell lysates and culture supernatants, were characterized by gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in combination with enzymatic degradation. Treatment with chondroitinase AC completely degraded the glycosaminoglycan moiety of the proteoglycans. Three to 4 chondroitin sulfate chains (average molecular mass = 26 kDa) were estimated for each of the two proteoglycans. Differences between the proteochondroitin sulfates (CSPG) were observed in the content of N-linked oligosaccharides. After chondroitinase AC treatment the resulting band in SDS-PAGE of the secreted CSPG was sensitive to treatment with endoglycosidase F (Endo F) which further reduced the molecular mass from 30 to 21.5 kDa, whereas the band of the cellular CSPG after chondroitinase AC treatment (molecular mass = 30 kDa) remained resistant to Endo F treatment. The composition of amino acids was different in the protein cores, suggesting differences in the primary structure. Both CSPG contained a high percentage of glycine and serine. For both CSPG a molecular mass of approximately 135 kDa was deduced from the hydrodynamic sizes of the glycosaminoglycan chains obtained after alkaline/borohydride treatment and the migration of the protein/oligosaccharide complexes in SDS-PAGE. 75% of all [S-35]sulfate-labeled molecules were found in the culture supernatant and 25% in the cellular fraction. S-35-Labeled material in the culture supernatant consisted exclusively of intact CSPG, whereas S-35-labeled molecules in the cellular preparation consisted largely of free chondroitin sulfate chains. Only 8.3% of the cellular material, isolated from the microsomal fraction, was intact CSPG. In pulse-chase experiments maximal secretion of CSPG was found after 4 h, comprising approximately 40% of totally synthesized CSPG. From these experiments we tentatively conclude that a small proportion of CSPG synthesized by LICR-LON-HMy2 cells is membrane-associated, a larger portion is secreted, and another portion is intracellularly degraded.
引用
收藏
页码:3402 / 3408
页数:7
相关论文
共 50 条
  • [1] RESPONSE OF A HUMAN B-LYMPHOBLASTOID CELL-LINE TO BCDF
    WYATT, R
    STORKUS, W
    DAWSON, J
    FASEB JOURNAL, 1988, 2 (06): : A1665 - A1665
  • [2] ISOLATION AND CHARACTERIZATION OF B-CELL DIFFERENTIATION FACTOR (BCDF) SECRETED FROM A HUMAN B-LYMPHOBLASTOID CELL-LINE
    YOSHIZAKI, K
    NAKAGAWA, T
    FUKUNAGA, K
    TSENG, LT
    YAMAMURA, Y
    KISHIMOTO, T
    JOURNAL OF IMMUNOLOGY, 1984, 132 (06): : 2948 - 2954
  • [3] MHC DELETION MUTANTS OF A B-LYMPHOBLASTOID CELL-LINE
    KOPPELMAN, B
    SALTER, R
    CRESSWELL, P
    HUMAN IMMUNOLOGY, 1986, 17 (02) : 129 - 130
  • [4] GENETIC INSTABILITY ON CHROMOSOME-16 IN A HUMAN B-LYMPHOBLASTOID CELL-LINE
    SMITH, LE
    GROSOVSKY, AJ
    SOMATIC CELL AND MOLECULAR GENETICS, 1993, 19 (06) : 515 - 527
  • [5] EXPRESSION OF MEMBRANE IGM BY A HUMAN B-LYMPHOBLASTOID CELL-LINE IN THE PRESENCE OF MONENSIN
    KUBO, RT
    PIGEON, ML
    MOLECULAR IMMUNOLOGY, 1983, 20 (03) : 345 - 348
  • [6] PURIFICATION AND PARTIAL BIOCHEMICAL-CHARACTERIZATION OF IGE-BINDING FACTORS SECRETED BY A HUMAN B-LYMPHOBLASTOID CELL-LINE
    SARFATI, M
    NAKAJIMA, T
    FROST, H
    KILCCHERR, E
    DELESPESSE, G
    IMMUNOLOGY, 1987, 60 (04) : 539 - 545
  • [7] T-CELL REGULATION OF B-LYMPHOBLASTOID CELL-LINE FUNCTION
    KEMPNER, DH
    LEIBOLD, W
    GATTI, RA
    CELLULAR IMMUNOLOGY, 1980, 55 (01) : 32 - 41
  • [8] INVITRO RESPONSES TO A B-LYMPHOBLASTOID CELL-LINE IN IMMUNODEFICIENCY DISEASES
    SULLIVAN, JL
    OCHS, HD
    WEDGWOOD, RJ
    JOURNAL OF CLINICAL IMMUNOLOGY, 1982, 2 (02) : 150 - 155
  • [9] VARIATIONS IN ANTIGEN EXPRESSION DURING THE CELL-CYCLE OF A HUMAN B-LYMPHOBLASTOID CELL-LINE
    GESCHE, AH
    ASHMAN, LK
    LEUKEMIA RESEARCH, 1985, 9 (01) : 147 - &
  • [10] RELEASE OF A FACTOR PREVENTING LYMPHOCYTE-ACTIVATION BY A HUMAN B-LYMPHOBLASTOID CELL-LINE
    WARRINGTON, RJ
    WILKINS, JA
    FEDERATION PROCEEDINGS, 1985, 44 (05) : 1696 - 1696